Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antineoplastic combinations comprising

Antineoplastic combinations comprising

US Patent 6617333 · Granted Sep 9, 2003

Estimated economic value: $179,756,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-2722020
Method for treating gefitinib resistant cancer2020
Method for treating gefitinib resistant cancer2020
Anti-tumor activity of CCI-779 in papillary renal cell cancer2014
Protein tyrosine kinase enzyme inhibitors2011
Use of CCI-779 as an antineoplastic agent2010
Method of potentiating chemotherapy and treating solid tumors2008
Protein tyrosine kinase enzyme inhibitors2008
Treatment of neoplasms with CCI-779/EKB-569 combination2008
Treatment of neoplasms with CCI-779/EKB-569 combination2008
Use of CCI-779 as an antineoplastic agent2007
Reversal of multidrug resistance in human colon carcinoma cells2005